EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Tumor microenvironment evolution in lung cancer: Spatio-temporal dynamics and clinical implications

Selma Dizdarević, Oleg Timofeev, Daniel Kazdal, Soni Savai Pullamsetti, Rocio Sotillo, Sonja Loges, Sebastian Kobold, Albrecht Stenzinger, Thorsten Stiewe, Rajkumar Savai

Seminars in Cancer Biology · 2026-06 · 123-124 · 1-26

DOI: 10.1016/j.semcancer.2026.04.003 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Seminars in Cancer Biology, 2026-06. Verfasst von Selma Dizdarević und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Lung Health (ILH), Member of the German Center for Lung Research (DZL), Member of the Cardio-Pulmonary Institute (CPI), Justus Liebig U…. Hauptthemen laut MEDLINE: Tumor Microenvironment, Lung Neoplasms, Carcinoma, Non-Small-Cell Lung. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 318 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsches Zentrum für Lungenforschung, European Commission, Elitenetzwerk Bayern.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The treatment of non-small cell lung cancer (NSCLC), a disease known for its aggressiveness and significant global impact, has substantially improved in recent decades. A notable shift from cytotoxic chemotherapy to more personalized approaches, such as targeted therapies and immunotherapies, has led to improved outcomes for some patients. However, the emergence of resistance remains a major challenge in clinical practice, highlighting the inherent adaptability of cancer cells. This adaptability extends beyond genetic and epigenetic changes within malignant cells, as the bidirectional crosstalk with the tumor microenvironment (TME) also plays a crucial role. This complex ecosystem, consisting of various cellular components (e.g., fibroblasts, endothelial cells, immune cells), extracellular matrix elements, and soluble factors, significantly influences tumor progression, metastasis, and treatment response. Therefore, a comprehensive understanding of how the TME evolves under the selective pressures of different therapies is essential for developing more durable and effective treatment strategies for NSCLC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor MicroenvironmentLung NeoplasmsCarcinoma, Non-Small-Cell LungHumansAnimalsDrug Resistance, Neoplasm

Stichwörter der Autor:innen

Clonal developmentLung cancerNon-small cell lung cancerSpatial heterogeneityTherapy resistanceTumor evolutionTumor microenvironment

Autor:innen und Institutionen

  • Institute for Lung Health (ILH), Member of the German Center for Lung Research (DZL), Member of the Cardio-Pulmonary Institute (CPI), Justus Liebig University, Giessen, Germany; Max Planck Institute for Heart and Lung R…
  • Philipps-Universität Marburg, Institute of Molecular Oncology, member of the DZL, Marburg, Germany.
  • Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany; Center for Personalized Medicine (ZPM), Heidelberg, Germany; Translational Lung Research Center (TLRC) Heidelberg, member of the DZL, Heidelbe…
  • Division of Molecular Thoracic Oncology, German Cancer Research Center (DKFZ), Member of the DZL and TLRC, Heidelberg, Germany.
  • Division of Personalized Medical Oncology (A420), German Cancer Research Center (DKFZ), Member of the DZL, Heidelberg, Germany; Department of Personalized Oncology, University Hospital Mannheim, Medical Faculty Mannheim…
  • Division of Clinical Pharmacology, LMU University Hospital, Member of the DZL, LMU Munich, Munich, Germany; Einheit für Klinische Pharmakologie (EKLiP), Helmholtz Zentrum München - German Research Center for Environment…

Förderung

  • Deutsches Zentrum für Lungenforschung
  • European Commission
  • Elitenetzwerk Bayern
  • Wilhelm Sander-Stiftung
  • Bayerische Forschungsstiftung
  • Melanoma Research Alliance
  • Hector Stiftung
  • José Carreras Leukämie-Stiftung

Zitieren

APA

Dizdarević, S., Timofeev, O., Kazdal, D., Pullamsetti, S. S., Sotillo, R., Loges, S., Kobold, S., Stenzinger, A., Stiewe, T., & Savai, R. (2026). Tumor microenvironment evolution in lung cancer: Spatio-temporal dynamics and clinical implications. Seminars in Cancer Biology, 123-124, 1-26. https://doi.org/10.1016/j.semcancer.2026.04.003

Vancouver

Dizdarević S, Timofeev O, Kazdal D, Pullamsetti SS, Sotillo R, Loges S, et al. Tumor microenvironment evolution in lung cancer: Spatio-temporal dynamics and clinical implications. Seminars in Cancer Biology. 2026;123-124:1-26. doi:10.1016/j.semcancer.2026.04.003

BibTeX
@article{Dizdarevi2026,
  author = {Dizdarević, Selma and Timofeev, Oleg and Kazdal, Daniel and Pullamsetti, Soni Savai and Sotillo, Rocio and Loges, Sonja and Kobold, Sebastian and Stenzinger, Albrecht and Stiewe, Thorsten and Savai, Rajkumar},
  title = {Tumor microenvironment evolution in lung cancer: Spatio-temporal dynamics and clinical implications},
  journal = {Seminars in Cancer Biology},
  year = {2026},
  volume = {123-124},
  pages = {1--26},
  doi = {10.1016/j.semcancer.2026.04.003}
}
Kostenlos starten →